MedTrace Logo

The Relationship Between Microbiota and Coronary Ectasia

NCT06384703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2024-04-25

No results posted yet for this study

Summary

Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.

Conditions

  • Coronary Ectasia
  • Microbial Disease

Interventions

DIAGNOSTIC_TEST

Taking blood for kit study

Taking blood for kit study (Elisa kit)

Sponsors & Collaborators

  • Necmettin Erbakan University

    collaborator OTHER

  • Konya Beyhekim Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Yakup Alsancak · Necmettin Erbakan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-03
Primary Completion
2021-04-25
Completion
2021-06-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06384703 on ClinicalTrials.gov